Home
News
Create
Screeners
Insights
Emmessar Biotech
26.
98
-0.26
(-0.95%)
Market Cap
₹13.47 Cr
PE Ratio
40.66
Industry
Chemicals
Buy
Sell
Company Performance:
1D
-0.95%
1M
+17.20%
6M
-16.73%
1Y
-25.84%
5Y
+39.87%
View Company Insights
Latest news about Emmessar Biotech
Emmessar Biotech & Nutrition Limited confirms non-applicability of SEBI circular regarding funding by large corporates
Apr 08, 2026
Emmessar Biotech & Nutrition Limited confirmed to BSE that it does not qualify as a large corporate under SEBI circular dated October 19, 2023. The company reported nil outstanding borrowings as on March 31, 2025, with credit rating and fine provisions marked as not applicable. This regulatory disclosure ensures compliance while clarifying the company's status regarding SEBI's framework for funding by large corporates.
Emmessar Biotech & Nutrition Limited Submits Q4FY26 SEBI Compliance Certificate
Apr 08, 2026
Emmessar Biotech & Nutrition Limited Reports Q3 FY26 Financial Results
Feb 11, 2026
Emmessar Biotech Nutrition Reports Q2 FY2026 Results: Revenue Dips, Records Quarterly Loss
Nov 12, 2025
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/ Block Deals
Stock Rental via SLBM
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation
IPO